Volume 94, Issue 2, Pages 228-230 (August 2018) Journal club    Kidney International  Volume 94, Issue 2, Pages 228-230 (August 2018) DOI: 10.1016/j.kint.2018.06.004 Copyright © 2018 Terms and Conditions

Figure 1 Myeloid angiogenic cells (MACs) from patients with type 1 diabetes (T1D) with microvascular complications (T1D+) adopt a M1 macrophage phenotype compared with T1D patients without microvascular complications (T1D–). ICAM, intercellular adhesion molecule 1; IL1b, interleukin 1 beta; ND, nondiabetic healthy volunteer; ns, not significant. From Chambers SEJ, O’Neill CL, Guduric-Fuchs J, et al. The vasoreparative function of myeloid angiogenic cells is impaired in diabetes through the induction of IL1β. Stem Cells. 2018;36:834–843. https://doi.org/10.1002/stem.2810. Copyright © 2018 Chambers et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial License. Kidney International 2018 94, 228-230DOI: (10.1016/j.kint.2018.06.004) Copyright © 2018 Terms and Conditions

Figure 2 Significant improvement of rickets by week 40, with a mean Thacher rickets severity total score of 0.8 in the every-2-week dosing group and 1.1 in the every-4-week dosing group (least-squares mean change, –1.1 with every-2-week dosing and –0.7 with every-4-week dosing; P < 0.001 for both comparisons). From N Engl J Med., Carpenter TO, Whyte MP, Imel EA, et al. Burosumab therapy in children with X-linked hypophosphatemia, Volume 378, Pages 1987–1998, Copyright © 2018 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society. Kidney International 2018 94, 228-230DOI: (10.1016/j.kint.2018.06.004) Copyright © 2018 Terms and Conditions